: Implantable devices form an integral part of the management of patients with heart failure (HF) and provide adjunctive therapies in addition to cornerstone drug treatment. Although the number of these devices is growing, only few are supported by robust evidence. Current devices aim to improve haemodynamics, improve reverse remodelling, or provide electrical therapy. A number of these devices have guideline recommendations and some have been shown to improve outcomes such as cardiac resynchronization therapy, implantable cardioverter-defibrillators and long-term mechanical support. For others, more evidence is still needed before large-scale implementation can be strongly advised. Of note, devices and drugs can work synergistically in HF as improved disease control with devices can allow for further optimization of drug therapy. Therefore, some devices might already be considered early in the disease trajectory of HF patients, while others might only be reserved for advanced HF. As such, device therapy should be integrated into HF care programmes. Unfortunately, implementation of devices, including those with the greatest evidence, in clinical care pathways is still suboptimal. This clinical consensus document of the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC) describes the physiological rationale behind device-provided therapy and also device-guided management, offers an overview of current implantable device options recommended by the guidelines and proposes a new integrated model of device therapy as a part of HF care.

Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC) / Mullens, Wilfried; Dauw, Jeroen; Gustafsson, Finn; Mebazaa, Alexandre; Steffel, Jan; Witte, Klaus K; Delgado, Victoria; Linde, Cecilia; Vernooy, Kevin; Anker, Stefan D; Chioncel, Ovidiu; Milicic, Davor; Hasenfuß, Gerd; Ponikowski, Piotr; Stephan von Bardeleben, Ralph; Koehler, Friedrich; Ruschitzka, Frank; Damman, Kevin; Schwammenthal, Ehud; Testani, Jeffrey M; Zannad, Faiez; Böhm, Michael; Cowie, Martin R; Dickstein, Kenneth; Jaarsma, Tiny; Filippatos, Gerasimos; Volterrani, Maurizio; Thum, Thomas; Adamopoulos, Stamatis; Cohen-Solal, Alain; Moura, Brenda; Rakisheva, Amina; Ristic, Arsen; Bayes-Genis, Antoni; Van Linthout, Sophie; Tocchetti, Carlo Gabriele; Savarese, Gianluigi; Skouri, Hadi; Adamo, Marianna; Amir, Offer; Yilmaz, Mehmet Birhan; Simpson, Maggie; Tokmakova, Mariya; González, Arantxa; Piepoli, Massimo; Seferovic, Petar; Metra, Marco; Coats, Andrew J S; Rosano, Giuseppe M C. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - (2024). [10.1002/ejhf.3150]

Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)

Tocchetti, Carlo Gabriele;Savarese, Gianluigi;Piepoli, Massimo;
2024

Abstract

: Implantable devices form an integral part of the management of patients with heart failure (HF) and provide adjunctive therapies in addition to cornerstone drug treatment. Although the number of these devices is growing, only few are supported by robust evidence. Current devices aim to improve haemodynamics, improve reverse remodelling, or provide electrical therapy. A number of these devices have guideline recommendations and some have been shown to improve outcomes such as cardiac resynchronization therapy, implantable cardioverter-defibrillators and long-term mechanical support. For others, more evidence is still needed before large-scale implementation can be strongly advised. Of note, devices and drugs can work synergistically in HF as improved disease control with devices can allow for further optimization of drug therapy. Therefore, some devices might already be considered early in the disease trajectory of HF patients, while others might only be reserved for advanced HF. As such, device therapy should be integrated into HF care programmes. Unfortunately, implementation of devices, including those with the greatest evidence, in clinical care pathways is still suboptimal. This clinical consensus document of the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC) describes the physiological rationale behind device-provided therapy and also device-guided management, offers an overview of current implantable device options recommended by the guidelines and proposes a new integrated model of device therapy as a part of HF care.
2024
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC) / Mullens, Wilfried; Dauw, Jeroen; Gustafsson, Finn; Mebazaa, Alexandre; Steffel, Jan; Witte, Klaus K; Delgado, Victoria; Linde, Cecilia; Vernooy, Kevin; Anker, Stefan D; Chioncel, Ovidiu; Milicic, Davor; Hasenfuß, Gerd; Ponikowski, Piotr; Stephan von Bardeleben, Ralph; Koehler, Friedrich; Ruschitzka, Frank; Damman, Kevin; Schwammenthal, Ehud; Testani, Jeffrey M; Zannad, Faiez; Böhm, Michael; Cowie, Martin R; Dickstein, Kenneth; Jaarsma, Tiny; Filippatos, Gerasimos; Volterrani, Maurizio; Thum, Thomas; Adamopoulos, Stamatis; Cohen-Solal, Alain; Moura, Brenda; Rakisheva, Amina; Ristic, Arsen; Bayes-Genis, Antoni; Van Linthout, Sophie; Tocchetti, Carlo Gabriele; Savarese, Gianluigi; Skouri, Hadi; Adamo, Marianna; Amir, Offer; Yilmaz, Mehmet Birhan; Simpson, Maggie; Tokmakova, Mariya; González, Arantxa; Piepoli, Massimo; Seferovic, Petar; Metra, Marco; Coats, Andrew J S; Rosano, Giuseppe M C. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - (2024). [10.1002/ejhf.3150]
File in questo prodotto:
File Dimensione Formato  
European J of Heart Fail - 2024 - Mullens - Integration of implantable device therapy in patients with heart failure A.pdf

solo utenti autorizzati

Licenza: Non specificato
Dimensione 1.16 MB
Formato Adobe PDF
1.16 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/951773
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact